🇺🇸 FDA
Pipeline program

Prednisone

GCO 14-2209

Approved small_molecule terminated

Quick answer

Prednisone for Crohn's Disease is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Crohn's Disease
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials